nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—F2—artery—metabolic syndrome X	0.0283	0.114	CbGeAlD
Dabigatran etexilate—F2—endothelium—metabolic syndrome X	0.0239	0.0967	CbGeAlD
Dabigatran etexilate—F2—blood vessel—metabolic syndrome X	0.022	0.0892	CbGeAlD
Dabigatran etexilate—Epigastric discomfort—Metformin—metabolic syndrome X	0.015	0.0798	CcSEcCtD
Dabigatran etexilate—UGT1A9—kidney—metabolic syndrome X	0.0133	0.0538	CbGeAlD
Dabigatran etexilate—UGT2B15—liver—metabolic syndrome X	0.0111	0.0449	CbGeAlD
Dabigatran etexilate—CES2—cardiovascular system—metabolic syndrome X	0.011	0.0444	CbGeAlD
Dabigatran etexilate—UGT2B7—kidney—metabolic syndrome X	0.0107	0.0434	CbGeAlD
Dabigatran etexilate—CES2—kidney—metabolic syndrome X	0.0107	0.0434	CbGeAlD
Dabigatran etexilate—F2—cardiovascular system—metabolic syndrome X	0.00982	0.0398	CbGeAlD
Dabigatran etexilate—CES2—adipose tissue—metabolic syndrome X	0.00966	0.0391	CbGeAlD
Dabigatran etexilate—F2—kidney—metabolic syndrome X	0.00961	0.0389	CbGeAlD
Dabigatran etexilate—NQO2—kidney—metabolic syndrome X	0.00958	0.0388	CbGeAlD
Dabigatran etexilate—CES1—cardiovascular system—metabolic syndrome X	0.00902	0.0365	CbGeAlD
Dabigatran etexilate—Contusion—Metformin—metabolic syndrome X	0.00902	0.0481	CcSEcCtD
Dabigatran etexilate—Chest discomfort—Metformin—metabolic syndrome X	0.00889	0.0474	CcSEcCtD
Dabigatran etexilate—NQO2—adipose tissue—metabolic syndrome X	0.00863	0.0349	CbGeAlD
Dabigatran etexilate—UGT1A9—liver—metabolic syndrome X	0.0084	0.034	CbGeAlD
Dabigatran etexilate—CES1—adipose tissue—metabolic syndrome X	0.00795	0.0322	CbGeAlD
Dabigatran etexilate—UGT2B7—liver—metabolic syndrome X	0.00677	0.0274	CbGeAlD
Dabigatran etexilate—CES2—liver—metabolic syndrome X	0.00677	0.0274	CbGeAlD
Dabigatran etexilate—F2—liver—metabolic syndrome X	0.00608	0.0246	CbGeAlD
Dabigatran etexilate—NQO2—liver—metabolic syndrome X	0.00605	0.0245	CbGeAlD
Dabigatran etexilate—Pain in extremity—Metformin—metabolic syndrome X	0.00571	0.0304	CcSEcCtD
Dabigatran etexilate—CES1—liver—metabolic syndrome X	0.00558	0.0226	CbGeAlD
Dabigatran etexilate—Liver function test abnormal—Metformin—metabolic syndrome X	0.00527	0.0281	CcSEcCtD
Dabigatran etexilate—Abdominal pain upper—Metformin—metabolic syndrome X	0.00522	0.0278	CcSEcCtD
Dabigatran etexilate—Nasopharyngitis—Metformin—metabolic syndrome X	0.00511	0.0272	CcSEcCtD
Dabigatran etexilate—Influenza—Metformin—metabolic syndrome X	0.00494	0.0263	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Metformin—metabolic syndrome X	0.00481	0.0256	CcSEcCtD
Dabigatran etexilate—ABCB1—blood vessel—metabolic syndrome X	0.00474	0.0192	CbGeAlD
Dabigatran etexilate—Abdominal discomfort—Metformin—metabolic syndrome X	0.00473	0.0252	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00459	0.0245	CcSEcCtD
Dabigatran etexilate—Infestation—Metformin—metabolic syndrome X	0.0044	0.0235	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Metformin—metabolic syndrome X	0.0044	0.0235	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00416	0.0222	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Metformin—metabolic syndrome X	0.00389	0.0207	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Metformin—metabolic syndrome X	0.00388	0.0207	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Metformin—metabolic syndrome X	0.00367	0.0195	CcSEcCtD
Dabigatran etexilate—Angiopathy—Metformin—metabolic syndrome X	0.00358	0.0191	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Metformin—metabolic syndrome X	0.00357	0.019	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Metformin—metabolic syndrome X	0.00356	0.019	CcSEcCtD
Dabigatran etexilate—Malnutrition—Metformin—metabolic syndrome X	0.00344	0.0183	CcSEcCtD
Dabigatran etexilate—Flatulence—Metformin—metabolic syndrome X	0.00339	0.0181	CcSEcCtD
Dabigatran etexilate—Syncope—Metformin—metabolic syndrome X	0.00308	0.0164	CcSEcCtD
Dabigatran etexilate—Palpitations—Metformin—metabolic syndrome X	0.00304	0.0162	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Metformin—metabolic syndrome X	0.00302	0.0161	CcSEcCtD
Dabigatran etexilate—Hypertension—Metformin—metabolic syndrome X	0.00297	0.0158	CcSEcCtD
Dabigatran etexilate—Chest pain—Metformin—metabolic syndrome X	0.00293	0.0156	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00291	0.0155	CcSEcCtD
Dabigatran etexilate—Infection—Metformin—metabolic syndrome X	0.00279	0.0149	CcSEcCtD
Dabigatran etexilate—Shock—Metformin—metabolic syndrome X	0.00276	0.0147	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Metformin—metabolic syndrome X	0.00275	0.0147	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Metformin—metabolic syndrome X	0.00275	0.0147	CcSEcCtD
Dabigatran etexilate—Skin disorder—Metformin—metabolic syndrome X	0.00273	0.0145	CcSEcCtD
Dabigatran etexilate—Hypotension—Metformin—metabolic syndrome X	0.00262	0.014	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00256	0.0136	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Metformin—metabolic syndrome X	0.0025	0.0133	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Metformin—metabolic syndrome X	0.00247	0.0132	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00242	0.0129	CcSEcCtD
Dabigatran etexilate—Fatigue—Metformin—metabolic syndrome X	0.00242	0.0129	CcSEcCtD
Dabigatran etexilate—Constipation—Metformin—metabolic syndrome X	0.0024	0.0128	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Metformin—metabolic syndrome X	0.0023	0.0122	CcSEcCtD
Dabigatran etexilate—Urticaria—Metformin—metabolic syndrome X	0.00223	0.0119	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Metformin—metabolic syndrome X	0.00222	0.0118	CcSEcCtD
Dabigatran etexilate—ABCB1—cardiovascular system—metabolic syndrome X	0.00211	0.00855	CbGeAlD
Dabigatran etexilate—ABCB1—kidney—metabolic syndrome X	0.00207	0.00837	CbGeAlD
Dabigatran etexilate—Asthenia—Metformin—metabolic syndrome X	0.00201	0.0107	CcSEcCtD
Dabigatran etexilate—Pruritus—Metformin—metabolic syndrome X	0.00199	0.0106	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Metformin—metabolic syndrome X	0.00192	0.0102	CcSEcCtD
Dabigatran etexilate—ABCB1—adipose tissue—metabolic syndrome X	0.00186	0.00754	CbGeAlD
Dabigatran etexilate—Dizziness—Metformin—metabolic syndrome X	0.00186	0.0099	CcSEcCtD
Dabigatran etexilate—Vomiting—Metformin—metabolic syndrome X	0.00178	0.00951	CcSEcCtD
Dabigatran etexilate—Rash—Metformin—metabolic syndrome X	0.00177	0.00944	CcSEcCtD
Dabigatran etexilate—Dermatitis—Metformin—metabolic syndrome X	0.00177	0.00943	CcSEcCtD
Dabigatran etexilate—Headache—Metformin—metabolic syndrome X	0.00176	0.00937	CcSEcCtD
Dabigatran etexilate—Nausea—Metformin—metabolic syndrome X	0.00167	0.00889	CcSEcCtD
Dabigatran etexilate—ABCB1—liver—metabolic syndrome X	0.00131	0.00529	CbGeAlD
Dabigatran etexilate—UGT2B7—Metabolism—EPHX2—metabolic syndrome X	0.000423	0.000749	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—MLXIPL—metabolic syndrome X	0.000423	0.000749	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000417	0.000738	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—HMGCR—metabolic syndrome X	0.000415	0.000734	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GOT2—metabolic syndrome X	0.000415	0.000734	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—metabolic syndrome X	0.000408	0.000722	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCL5—metabolic syndrome X	0.0004	0.000708	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—G6PC2—metabolic syndrome X	0.000398	0.000704	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.000396	0.000699	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000393	0.000695	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—FMO3—metabolic syndrome X	0.000386	0.000683	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—GHRL—metabolic syndrome X	0.000383	0.000678	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000382	0.000675	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000379	0.00067	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—IGF2—metabolic syndrome X	0.000377	0.000667	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—ACE—metabolic syndrome X	0.000371	0.000657	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—SLC2A4—metabolic syndrome X	0.00037	0.000655	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ABCA1—metabolic syndrome X	0.00037	0.000655	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—APOB—metabolic syndrome X	0.000366	0.000648	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—TGFB1—metabolic syndrome X	0.000366	0.000648	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000365	0.000646	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000362	0.00064	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GOT1—metabolic syndrome X	0.000358	0.000634	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GGT1—metabolic syndrome X	0.000358	0.000634	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PLA2G4A—metabolic syndrome X	0.000356	0.00063	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000355	0.000627	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000345	0.00061	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—EPHX2—metabolic syndrome X	0.000344	0.000609	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—MLXIPL—metabolic syndrome X	0.000344	0.000609	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—FABP4—metabolic syndrome X	0.000339	0.000599	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—AGT—metabolic syndrome X	0.000335	0.000592	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—CD36—metabolic syndrome X	0.000332	0.000588	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000325	0.000575	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—G6PC2—metabolic syndrome X	0.000324	0.000572	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HSD11B1—metabolic syndrome X	0.000321	0.000568	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	0.000317	0.00056	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000308	0.000545	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000308	0.000544	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—APOB—metabolic syndrome X	0.000304	0.000538	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000298	0.000527	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—TGFB1—metabolic syndrome X	0.000298	0.000526	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—IGF2—metabolic syndrome X	0.000297	0.000525	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PLA2G4A—metabolic syndrome X	0.000296	0.000523	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000295	0.000522	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000292	0.000516	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—LPL—metabolic syndrome X	0.00029	0.000514	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—APOA1—metabolic syndrome X	0.00029	0.000513	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—G6PD—metabolic syndrome X	0.000286	0.000506	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	0.000282	0.000498	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.000282	0.000498	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—GHRL—metabolic syndrome X	0.00028	0.000495	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HDAC3—metabolic syndrome X	0.000279	0.000494	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CD36—metabolic syndrome X	0.000276	0.000488	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCL2—metabolic syndrome X	0.000276	0.000487	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—FABP4—metabolic syndrome X	0.000275	0.000486	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GCKR—metabolic syndrome X	0.000273	0.000483	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—LPA—metabolic syndrome X	0.000273	0.000483	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	0.00027	0.000478	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CNR1—metabolic syndrome X	0.000265	0.000469	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PLA2G6—metabolic syndrome X	0.000264	0.000467	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOA5—metabolic syndrome X	0.000262	0.000463	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HSD11B1—metabolic syndrome X	0.000261	0.000461	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PPARA—metabolic syndrome X	0.000257	0.000454	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000253	0.000447	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HDAC3—metabolic syndrome X	0.00025	0.000443	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AGT—metabolic syndrome X	0.000248	0.000439	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000246	0.000435	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—APOE—metabolic syndrome X	0.000243	0.000431	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—TRIB3—metabolic syndrome X	0.000243	0.00043	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—IGF1—metabolic syndrome X	0.000242	0.000429	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000241	0.000427	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—APOA1—metabolic syndrome X	0.000241	0.000426	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—AGT—metabolic syndrome X	0.000235	0.000416	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—G6PD—metabolic syndrome X	0.000232	0.000411	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—LEP—metabolic syndrome X	0.000231	0.000408	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SERPINE1—metabolic syndrome X	0.00023	0.000407	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—ALB—metabolic syndrome X	0.00023	0.000406	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000229	0.000406	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HDAC3—metabolic syndrome X	0.000227	0.000401	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000226	0.0004	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000224	0.000396	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TGFB1—metabolic syndrome X	0.000223	0.000395	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GCKR—metabolic syndrome X	0.000222	0.000392	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—LPA—metabolic syndrome X	0.000222	0.000392	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—NOS3—metabolic syndrome X	0.00022	0.000389	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NAMPT—metabolic syndrome X	0.000218	0.000386	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TRIB3—metabolic syndrome X	0.000218	0.000386	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RBP4—metabolic syndrome X	0.000218	0.000386	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	0.000217	0.000384	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.000217	0.000384	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—LIPC—metabolic syndrome X	0.000217	0.000383	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GCK—metabolic syndrome X	0.000217	0.000383	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOC3—metabolic syndrome X	0.000215	0.000381	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PLA2G6—metabolic syndrome X	0.000215	0.00038	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000213	0.000377	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOA5—metabolic syndrome X	0.000213	0.000376	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PPARG—metabolic syndrome X	0.000212	0.000375	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CETP—metabolic syndrome X	0.000209	0.00037	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TNF—metabolic syndrome X	0.000208	0.000368	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—INS—metabolic syndrome X	0.000208	0.000368	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000206	0.000365	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL5—metabolic syndrome X	0.000205	0.000363	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000205	0.000362	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000202	0.000358	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SCARB1—metabolic syndrome X	0.0002	0.000354	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.0002	0.000354	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—TRIB3—metabolic syndrome X	0.000198	0.00035	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—INS—metabolic syndrome X	0.000197	0.000349	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	0.000196	0.000346	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SREBF1—metabolic syndrome X	0.000194	0.000344	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CCL2—metabolic syndrome X	0.000194	0.000343	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOC3—metabolic syndrome X	0.000193	0.000342	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ALB—metabolic syndrome X	0.000191	0.000337	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—IGF1—metabolic syndrome X	0.000191	0.000337	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AGT—metabolic syndrome X	0.000189	0.000334	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HMGCR—metabolic syndrome X	0.000189	0.000334	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GOT2—metabolic syndrome X	0.000189	0.000334	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	0.000184	0.000325	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—NOS3—metabolic syndrome X	0.000182	0.000323	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	0.000179	0.000317	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NAMPT—metabolic syndrome X	0.000177	0.000313	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—FMO3—metabolic syndrome X	0.000177	0.000313	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000176	0.000312	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—LIPC—metabolic syndrome X	0.000176	0.000312	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GCK—metabolic syndrome X	0.000176	0.000312	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOC3—metabolic syndrome X	0.000175	0.00031	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR2C—metabolic syndrome X	0.000174	0.000308	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	0.000173	0.000305	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AGT—metabolic syndrome X	0.000172	0.000304	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CETP—metabolic syndrome X	0.00017	0.000301	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CYBA—metabolic syndrome X	0.000169	0.000299	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SLC2A4—metabolic syndrome X	0.000169	0.000298	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ABCA1—metabolic syndrome X	0.000169	0.000298	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTGS2—metabolic syndrome X	0.000167	0.000295	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	0.000166	0.000294	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GHRL—metabolic syndrome X	0.000165	0.000292	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GGT1—metabolic syndrome X	0.000163	0.000289	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GOT1—metabolic syndrome X	0.000163	0.000289	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SCARB1—metabolic syndrome X	0.000163	0.000288	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.000158	0.00028	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SREBF1—metabolic syndrome X	0.000158	0.000279	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	0.000158	0.000279	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—EPHX2—metabolic syndrome X	0.000158	0.000279	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CNR1—metabolic syndrome X	0.000156	0.000277	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HMGCR—metabolic syndrome X	0.000154	0.000272	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GOT2—metabolic syndrome X	0.000154	0.000272	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	0.000152	0.000269	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—G6PC2—metabolic syndrome X	0.000148	0.000262	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TGFB1—metabolic syndrome X	0.000145	0.000257	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL2—metabolic syndrome X	0.000141	0.00025	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	0.000139	0.000245	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOB—metabolic syndrome X	0.000139	0.000245	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ABCA1—metabolic syndrome X	0.000137	0.000242	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SLC2A4—metabolic syndrome X	0.000137	0.000242	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PLA2G4A—metabolic syndrome X	0.000135	0.000238	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000134	0.000237	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GGT1—metabolic syndrome X	0.000133	0.000235	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GOT1—metabolic syndrome X	0.000133	0.000235	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—LPL—metabolic syndrome X	0.000132	0.000234	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IGF2—metabolic syndrome X	0.000128	0.000226	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—FABP4—metabolic syndrome X	0.000126	0.000223	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CD36—metabolic syndrome X	0.000126	0.000222	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOB—metabolic syndrome X	0.000124	0.00022	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL5—metabolic syndrome X	0.000121	0.000215	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000121	0.000214	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	0.00012	0.000212	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LPL—metabolic syndrome X	0.000119	0.00021	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARA—metabolic syndrome X	0.000117	0.000207	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AGT—metabolic syndrome X	0.000113	0.0002	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOB—metabolic syndrome X	0.000113	0.000199	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOE—metabolic syndrome X	0.000111	0.000196	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.00011	0.000195	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.00011	0.000195	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOA1—metabolic syndrome X	0.00011	0.000194	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PLA2G4A—metabolic syndrome X	0.00011	0.000194	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—LPL—metabolic syndrome X	0.000107	0.00019	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—G6PD—metabolic syndrome X	0.000107	0.000189	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HDAC3—metabolic syndrome X	0.000104	0.000184	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.000103	0.000182	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CD36—metabolic syndrome X	0.000102	0.000181	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LPA—metabolic syndrome X	0.000102	0.00018	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GCKR—metabolic syndrome X	0.000102	0.00018	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AGT—metabolic syndrome X	0.000101	0.000179	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—AKT1—metabolic syndrome X	0.000101	0.000179	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LEP—metabolic syndrome X	9.94e-05	0.000176	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOE—metabolic syndrome X	9.94e-05	0.000176	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	9.85e-05	0.000174	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOA1—metabolic syndrome X	9.83e-05	0.000174	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOA5—metabolic syndrome X	9.75e-05	0.000172	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARG—metabolic syndrome X	9.66e-05	0.000171	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARA—metabolic syndrome X	9.5e-05	0.000168	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—INS—metabolic syndrome X	9.47e-05	0.000168	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	9.3e-05	0.000164	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AGT—metabolic syndrome X	9.2e-05	0.000163	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—TRIB3—metabolic syndrome X	9.07e-05	0.00016	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOE—metabolic syndrome X	9.01e-05	0.000159	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOA1—metabolic syndrome X	8.91e-05	0.000158	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IRS1—metabolic syndrome X	8.87e-05	0.000157	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	8.72e-05	0.000154	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALB—metabolic syndrome X	8.68e-05	0.000154	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—INS—metabolic syndrome X	8.49e-05	0.00015	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AKT1—metabolic syndrome X	8.38e-05	0.000148	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL2—metabolic syndrome X	8.36e-05	0.000148	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NOS3—metabolic syndrome X	8.31e-05	0.000147	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IGF1—metabolic syndrome X	8.21e-05	0.000145	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NAMPT—metabolic syndrome X	8.13e-05	0.000144	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LIPC—metabolic syndrome X	8.08e-05	0.000143	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GCK—metabolic syndrome X	8.08e-05	0.000143	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOC3—metabolic syndrome X	8.03e-05	0.000142	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARG—metabolic syndrome X	7.85e-05	0.000139	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SERPINE1—metabolic syndrome X	7.8e-05	0.000138	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CETP—metabolic syndrome X	7.8e-05	0.000138	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—INS—metabolic syndrome X	7.7e-05	0.000136	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	7.65e-05	0.000135	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS2—metabolic syndrome X	7.6e-05	0.000134	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SCARB1—metabolic syndrome X	7.47e-05	0.000132	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NOS3—metabolic syndrome X	7.45e-05	0.000132	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SREBF1—metabolic syndrome X	7.25e-05	0.000128	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALB—metabolic syndrome X	7.06e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HMGCR—metabolic syndrome X	7.05e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GOT2—metabolic syndrome X	7.05e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	6.91e-05	0.000122	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NOS3—metabolic syndrome X	6.75e-05	0.000119	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AKT1—metabolic syndrome X	6.38e-05	0.000113	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	6.28e-05	0.000111	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ABCA1—metabolic syndrome X	6.28e-05	0.000111	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6—metabolic syndrome X	6.28e-05	0.000111	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS2—metabolic syndrome X	6.17e-05	0.000109	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GOT1—metabolic syndrome X	6.09e-05	0.000108	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GGT1—metabolic syndrome X	6.09e-05	0.000108	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AKT1—metabolic syndrome X	5.8e-05	0.000102	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOB—metabolic syndrome X	5.16e-05	9.13e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	5.02e-05	8.88e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LPL—metabolic syndrome X	4.93e-05	8.72e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TGFB1—metabolic syndrome X	4.92e-05	8.71e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CD36—metabolic syndrome X	4.69e-05	8.29e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARA—metabolic syndrome X	4.36e-05	7.7e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AGT—metabolic syndrome X	4.22e-05	7.46e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOE—metabolic syndrome X	4.13e-05	7.31e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOA1—metabolic syndrome X	4.09e-05	7.23e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AKT1—metabolic syndrome X	3.82e-05	6.75e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6—metabolic syndrome X	3.71e-05	6.56e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARG—metabolic syndrome X	3.6e-05	6.37e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—INS—metabolic syndrome X	3.53e-05	6.24e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKT1—metabolic syndrome X	3.42e-05	6.05e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALB—metabolic syndrome X	3.24e-05	5.73e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AKT1—metabolic syndrome X	3.1e-05	5.49e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NOS3—metabolic syndrome X	3.1e-05	5.48e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS2—metabolic syndrome X	2.83e-05	5.01e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.42e-05	2.52e-05	CbGpPWpGaD
